NPPA directs pharma companies to furnish PTR and MAT values for the formulations mentioned in the NELM,2015
The National Pharmaceutical Pricing Authority (“NPPA”), vide office memorandum dated 7th December, 2017, has directed all concerned manufacturing / marketing companies to furnish the Price To Retailer (“PTR”) and the Moving Annual Turnover (“MAT”), in value terms, for the formulations mentioned in the National List of Essential Medicines (“NLEM”), 2015, by 22ndDecember, 2017 to enable NPPA to take appropriate action for fixing ceiling price under the provisions of the Drug Price Control Order (“DPCO”), 2013.
NPPA also informed that:
- The PTR and MAT, so furnished, must be duly self-attested with the proper authorized signature and seal of the authorized officer of the companies.
- In case manufacturing / marketing companies fail to provide requisite data on or before deadline, NPPA will have no option but to fix the ceiling price of these formulations based on other available information.
As the PTR and MAT of these formulations are not captured by the All India Organisation of Chemists and Druggists [Pharmatrac], the NPPA, with reference to office memorandum of even number dated 6th July, 2017 dealing with the consolidated list of NLEM, 2015 formulations under the DPCO, 2013 (as on 30th November,2017), issued this Office Memorandum.
Please refer to the hyperlinked source below for further details and the list of formulations under NLEM, 2015.